Based on part 1 of the ESSENCE trial, Novo Nordisk has also filed for regulatory approval in the EU in February 2025, with a subsequent filing in Japan in May 2025
Whether at home, travelling, or during a busy schedule, the spray can be used discreetly and efficiently, ensuring consistent results without disrupting daily activities
The gap between 10mg and 15mg (about 1 percentage point) is notably smaller than the gap between 5mg and 10mg (about 5 percentage points)
Could my genetics affect how likely I am to experience constipation on semaglutide
The overall structure of the GLP-1R ECD is essentially unchanged compared to the peptide-bound structures (pdb codes: 3IOL and 3C5T), except for changes of certain sidechain conformations
New, unusually severe, or increasingly frequent migraines should be discussed with the prescribing clinician